Financials

News Ideas Technicals Forecast

PIRS fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to Pieris Pharmaceuticals, Inc. operating, investing, and financing activities

PIRS free cash flow for Q4 23 is -19.66 M USD. For 2023, PIRS free cash flow was -53.99 M USD and operating cash flow was -53.82 M USD.

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: USD

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—